Alembic Pharma gains on USFDA nod for Fluorouracil injection 0 06.03.2023 08:43 Business Standard Alembic Pharmaceuticals rose 3.46% to Rs 518.90 after the pharma company announced that it has received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Fluorouracil injection USP, Pharmacy Bulk Vial. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
